688139
vs
ABT
688139
ABT
Over the past 12 months, Qingdao Haier Biomedical Co Ltd has significantly outperformed ABT, delivering a return of +2% compared to the ABT's 30% drop.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
688139
ABT
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Intrinsic Value
20.53
CNY
Overvaluation 37%
ABT
Intrinsic Value
100.9
USD
Undervaluation 8%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
32.82
CNY
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
92.82
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
688139, ABT
688139, ABT
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Qingdao Haier Biomedical Co Ltd
Revenue
|
|||||||||||
|
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
688139, ABT
688139, ABT
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
|||||||||
|
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Qingdao Haier Biomedical Co Ltd
46.4%
ABT
56.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
Operating Margin
Qingdao Haier Biomedical Co Ltd
9.1%
ABT
18.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
Net Margin
Qingdao Haier Biomedical Co Ltd
10.8%
ABT
13.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
FCF Margin
Qingdao Haier Biomedical Co Ltd
6.4%
ABT
16.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
ROE
Qingdao Haier Biomedical Co Ltd
5.7%
ABT
12.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
ROA
Qingdao Haier Biomedical Co Ltd
4.3%
ABT
7.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
ROIC
Qingdao Haier Biomedical Co Ltd
5.8%
ABT
9.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
ROCE
Qingdao Haier Biomedical Co Ltd
4.5%
ABT
12.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Qingdao Haier Biomedical Co Ltd | ||||
|
|
Abbott Laboratories | ||||
Solvency Comparison
Qingdao Haier Biomedical Co Ltd
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
688139, ABT
688139, ABT
Performance By Year
688139, ABT
688139, ABT
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 688139 to other stocks
ISRG
Intuitive Surgical Inc
More expensive
vs Qingdao Haier Biomedical Co Lt...
SYK
Stryker Corp
Cheaper
vs Qingdao Haier Biomedical Co Lt...
MDT
Medtronic PLC
Cheaper
vs Qingdao Haier Biomedical Co Lt...
BSX
Boston Scientific Corp
Cheaper
vs Qingdao Haier Biomedical Co Lt...
Select Stock to Compare
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
